ArticleThe Lancet. Infectious diseases2022
Trends in the global burden of lower respiratory infections: the knowns and the unknowns.
Article in The Lancet. Infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Life-course restructuring of infectious mortality in China, 2004-2021: a national surveillance study.Frontiers in public health · 2026Article
- Direct medical costs of respiratory infections in adults: A multicenter retrospective analysis in Thai Nguyen, Vietnam.PloS one · 2026Article
- Advances and prospects of respiratory mucosal vaccines: mechanisms, technologies, and clinical applications.NPJ vaccines · 2025Review
- Disparities and inequalities of lower respiratory infections in Iran, 1990-2021: the role of socioeconomic and demographic factors.BMC infectious diseases · 2025Article
- The bacterial etiology and antimicrobial susceptibility of lower respiratory tract infections in Vietnam.Annals of clinical microbiology and antimicrobials · 2025Article
- Vaccine Development for Human Pneumoviruses.Vaccines · 2025Review
- Global burden of reported lower respiratory system fungal infection.Frontiers in cellular and infection microbiology · 2025Article
- The application prospect of metagenomic next-generation sequencing technology in diagnosing suspected lower respiratory tract infections.Frontiers in cellular and infection microbiology · 2025Article
- A human behavior-based model for respiratory infectious diseases prediction.Frontiers in public health · 2025Article
- A 32-year trend analysis of lower respiratory infections in children under 5: insights from the global burden of disease study 2021.Frontiers in public health · 2025Article
- Respiratory Delivery ofPharmaceutics · 2024Article
- Lung antimicrobial proteins and peptides: from host defense to therapeutic strategies.Physiological reviews · 2024Review
- Advances in nucleic acid aptamer-based detection of respiratory virus and bacteria: a mini review.Virology journal · 2024Review
- Monocyte Production of C1q Potentiates CD8American journal of respiratory cell and molecular biology · 2024Article
- Article
- Aggravated exposure risks of children to multipath transmitted pathogens in indoor environments.iScience · 2023Article
- Clinical Presentation and Co-Detection of Respiratory Pathogens in Children Under 5 Years with Non-COVID-19 Bacterial and Viral Respiratory Tract Infections: A Prospective Study in Białystok, Poland (2021-2022).Medical science monitor : international medical journal of experimental and clinical research · 2023Article
- DifferentialFrontiers in immunology · 2023Article
- Nanopore-based metagenomic sequencing: a diagnostic tool in respiratory tract infection.ERJ open research · 2022Article
- Phage therapy in the management of respiratory and pulmonary infections: a systematic review.Therapeutic advances in infectious diseaseReview
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
35964616What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.